BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Y, Jin Y, Li J, Zhao L, Li Z, Xu J, Zhao F, Feng J, Chen H, Fang C, Shilpakar R, Wei Y. Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis. Front Physiol 2018;9:470. [PMID: 29780327 DOI: 10.3389/fphys.2018.00470] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Fukui H. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far? Diseases. 2019;7. [PMID: 31726747 DOI: 10.3390/diseases7040058] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
2 Meng X, Li S, Li Y, Gan RY, Li HB. Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics. Nutrients. 2018;10:1457. [PMID: 30297615 DOI: 10.3390/nu10101457] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
3 Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Shirokova E. Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link? World J Clin Cases 2021;9:9320-32. [PMID: 34877269 DOI: 10.12998/wjcc.v9.i31.9320] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Simon M, Reinbeck AL, Wessel C, Heindirk J, Jelenik T, Kaul K, Arreguin-cano J, Strom A, Blaut M, Bäckhed F, Burkart V, Roden M. Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in nonobese diabetic mice. Journal of Biological Chemistry 2020;295:969-80. [DOI: 10.1016/s0021-9258(17)49908-x] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
5 Simon M, Reinbeck AL, Wessel C, Heindirk J, Jelenik T, Kaul K, Arreguin-cano J, Strom A, Blaut M, Bäckhed F, Burkart V, Roden M. Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in nonobese diabetic mice. J Biol Chem 2020;295:969-80. [DOI: 10.1074/jbc.ra119.010816] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
6 Mehtani R, Roy A, Singh V. Gut Microbial Metagenomics in ACLF: The Causality-Association Conundrum. Gastroenterology 2021;160:2205. [PMID: 33387519 DOI: 10.1053/j.gastro.2020.12.055] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Manzoor R, Ahmed W, Afify N, Memon M, Yasin M, Memon H, Rustom M, Al Akeel M, Alhajri N. Trust Your Gut: The Association of Gut Microbiota and Liver Disease. Microorganisms 2022;10:1045. [DOI: 10.3390/microorganisms10051045] [Reference Citation Analysis]
8 Xu S, Xiang C, Wu J, Teng Y, Wu Z, Wang R, Lu B, Zhan Z, Wu H, Zhang J. Tongue Coating Bacteria as a Potential Stable Biomarker for Gastric Cancer Independent of Lifestyle. Dig Dis Sci 2021;66:2964-80. [PMID: 33044677 DOI: 10.1007/s10620-020-06637-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Wei S, Bahl MI, Baunwall SMD, Hvas CL, Licht TR. Determining Gut Microbial Dysbiosis: a Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances. Appl Environ Microbiol 2021;87:e00395-21. [PMID: 33741632 DOI: 10.1128/AEM.00395-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Kudryavtseva A, Krasnov G. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. World J Gastroenterol 2022; 28(10): 1067-1077 [DOI: 10.3748/wjg.v28.i10.1067] [Reference Citation Analysis]